Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened), confirmed by an imaging test such as an echocardiogram, MRI, or CT scan, meeting specific thickness measurements based on genetic testing results (confirm with trial site)
- People whose hypertrophic cardiomyopathy does not cause a significant blockage of blood flow out of the heart (with a specific pressure measurement below 30 mmHg)
- People who also have persistent atrial fibrillation (an irregular heart rhythm lasting more than 7 days but less than 3 years) with symptoms that have not been controlled by medication
- People who are able to understand the trial information and sign a written consent form to participate
Who may not be able to join:
- People whose left atrial chamber of the heart is larger than 60 mm as measured by echocardiogram
- People for whom blood-thinning medication is not medically safe
- People whose heart pumping function is significantly reduced (ejection fraction of 40% or less)
- People who have blood clots in the left side of the heart
- People who also have a heart artery or heart valve problem that requires a procedure or surgery
- People who have had a stroke caused by reduced blood flow within the past 2 months
- People who have previously had a cardiac ablation procedure
- People with an overactive or underactive thyroid that is not currently controlled
- People with end-stage kidney failure
- People who are already participating in another clinical trial
- People who are pregnant, breastfeeding, or of childbearing age and not using a reliable form of contraception
- People who currently have a blood infection or an active infection
- People whose chest anatomy makes thoracoscopic (keyhole chest) surgery unsuitable, such as those with a history of chest surgery or radiation therapy to the chest
- People who are unwilling or unable to attend all required appointments and follow-up visits related to the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhe Zheng, MD.PhD, Chinese Academy of Medical Sciences, Fuwai Hospital
Phone: +86-010-88396051
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Freedom from documented recurrence (off-AADs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.